title: [CORRECTION OF BLOOD CIRCULATION IN THE PROSTATE IN PATIENTS WITH CHRONIC PROSTATITIS ASSOCIATED WITH UROGENITAL INFECTIONS].
abstract: The aim of the study was to assess the effect of a combined preparation of Vitaprost on blood supply and microcirculation in the prostate gland in 35 patients with chronic infectious urethral prostatitis. The effectiveness of treatment was estimated by a combination of clinical, bacteriological and instrumental diagnostic methods. Transrectal ultrasonography with color Doppler and laser Doppler flowmetry were used to estimate all components of blood circulation in the prostate. Examination results obtained before and after treatment showed better clinical outcomes and improved parameters of blood flow and microcirculation in the prostate in patients receiving Vitapost. These results indicate that combination therapy including Vitaprost is effective in correcting blood flow and microcirculatory disorders of the prostate and can be utilized in the treatment of chronic infectious urethral prostatitis.
authors.forename: Ju S
authors.initials: JS
authors.lastname: Kondrat'eva
authors.forename: A I
authors.initials: AI
authors.lastname: Nejmark
authors.forename: Ja D
authors.initials: JD
authors.lastname: Zheltikova
authors.forename: E A
authors.initials: EA
authors.lastname: Subbotin
mesh_terms: D000284:Administration, Oral; D000285:Administration, Rectal; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D006867:Hydrolases / Q000008:administration & dosage / Q000627:therapeutic use*; D017078:Laser-Doppler Flowmetry; D008297:Male; D008833:Microcirculation / Q000187:drug effects*; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D011467:Prostate / Q000098:blood supply* / Q000187:drug effects; D011472:Prostatitis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D012431:Rutin / Q000008:administration & dosage / Q000627:therapeutic use*; D013488:Suppositories; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D010455:Peptides; D013488:Suppositories; C524164:Vitaprost; D012431:Rutin; C023295:Wobenzym; D006867:Hydrolases